Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Research & Development: 2019-2024

Historic Research & Development for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $367.6 million.

  • Beam Therapeutics' Research & Development rose 16.46% to $109.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.8 million, marking a year-over-year increase of 1.38%. This contributed to the annual value of $367.6 million for FY2024, which is 15.96% down from last year.
  • As of FY2024, Beam Therapeutics' Research & Development stood at $367.6 million, which was down 15.96% from $437.4 million recorded in FY2023.
  • Over the past 5 years, Beam Therapeutics' Research & Development peaked at $437.4 million during FY2023, and registered a low of $103.2 million during FY2020.
  • Its 3-year average for Research & Development is $372.2 million, with a median of $367.6 million in 2024.
  • Per our database at Business Quant, Beam Therapeutics' Research & Development spiked by 275.16% in 2021 and then fell by 19.50% in 2022.
  • Yearly analysis of 5 years shows Beam Therapeutics' Research & Development stood at $103.2 million in 2020, then surged by 275.16% to $387.1 million in 2021, then fell by 19.50% to $311.6 million in 2022, then soared by 40.37% to $437.4 million in 2023, then fell by 15.96% to $367.6 million in 2024.